Stock TLX TELIX PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Market Closed - Australian S.E.
Other stock markets
 02:10:05 2024-04-29 EDT 		5-day change 1st Jan Change
15.51 AUD +4.02% Intraday chart for Telix Pharmaceuticals Limited +10.00% +53.87%
04-18 Jarden Adjusts Telix Pharmaceuticals Price Target to AU$13.52 from AU$13.27, Keeps at Buy MT
04-17 Telix Pharmaceuticals Limited Reports Unaudited Revenue Results for the First Quarter Ended 31 March 2024 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Telix Pharmaceuticals Limited Reaffirms Revenue Guidance for the Year 2024
Telix Pharmaceuticals Logs Nearly $115 Million Revenue in Q1
Telix Pharmaceuticals Limited Announces FDA Fast Track Designation for TLX101-CDx
Telix Pharmaceuticals Limited schließt die Übernahme von ARTMS, Inc. ab.
Telix Pharmaceuticals Limited completa la adquisición de ARTMS Inc.
Telix Pharmaceuticals Completes Acquisition of Canadian Firm ARTMS
Telix Pharmaceuticals Limited completed the acquisition of ARTMS, INC.
Telix Pharmaceuticals Completes Acquisition of IsoTherapeutics Group
Telix Pharmaceuticals Limited completed the acquisition of IsoTherapeutics Group, LLC for $8.1 million.
Telix Pharmaceuticals Limited Announces First Patient Dosed in Italian Named Patient ( Early Access) Program for TLX250-CDx Telix's Kidney Cancer Imaging Agent
Telix Pharmaceuticals Appoints Group COO; Shares Down 4%
Telix Pharmaceuticals to Buy Canadian Radioisotope Production Firm ARTMS
Telix Pharmaceuticals Jumps 7% on IsoTherapeutics Group Acquisition Deal
Telix Pharmaceuticals Posts 214% Surge in FY23 Revenue; Returns to Profit
Telix Pharmaceuticals Limited Provides Earnings Guidance for Full Year Revenue 2024
Telix Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023
Telix Pharmaceuticals to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
Australia shares led higher by Financials; US inflation in focus
Australia's Telix Pharmaceuticals jumps on potential US listing
Telix Pharmaceuticals Mulls US IPO
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TLX Stock
  4. News Telix Pharmaceuticals Limited
  5. Other languages